# Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan

> **NCT01226550** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 18 (actual)

## Conditions studied

- Peritoneal Carcinosis (PC)

## Interventions

- **PROCEDURE:** cytoreductive surgery and HIPEC

## Key facts

- **NCT ID:** NCT01226550
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01226550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01226550, "Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01226550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*